Travere Therapeutics (TVTX) Gains from Investment Securities (2013 - 2026)
Travere Therapeutics posted quarterly Gains from Investment Securities of $4000.0 for Q1 2026, down 95.18% year-on-year from $83000.0 in Q1 2025, and up 109.3% on a QoQ basis from -$43000.0 in Q4 2025.
Travere Therapeutics (TVTX) has 14 years of Gains from Investment Securities data on file, last reported at $4000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 95.18% year-over-year to $4000.0; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 1020.33% YoY), and the FY2025 full-year result was $1.5 million, up 3542.5% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at $4000.0, up from -$43000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $9.1 million in Q1 2022 and bottomed at -$2.2 million in Q4 2023.
- The 5-year median for Gains from Investment Securities is $1.3 million (2023), against an average of $2.1 million.
- The widest annual swing landed in 2022, when Gains from Investment Securities jumped 597.53%; it then plunged 207.5% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $6.4 million in 2022, then sank by 134.35% to -$2.2 million in 2023, then soared by 101.83% to $40000.0 in 2024, then slumped by 207.5% to -$43000.0 in 2025, then soared by 109.3% to $4000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $4000.0 (Q1 2026), -$43000.0 (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Sep 30, 2025 | 1.56 Mn |
| Sep 30, 2025 | 1.56 Mn |
| Jun 30, 2025 | -146,000.00 |
| Jun 30, 2025 | -146,000.00 |
| Mar 31, 2025 | 83,000.00 |
| Mar 31, 2025 | 83,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Dec 31, 2023 | -2.19 Mn |
| Dec 31, 2023 | -2.19 Mn |
| Sep 30, 2023 | 3.09 Mn |
| Sep 30, 2023 | 3.09 Mn |
| Jun 30, 2023 | 1.84 Mn |
| Jun 30, 2023 | 1.84 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 6.37 Mn |
| Dec 31, 2022 | 6.37 Mn |
| Sep 30, 2022 | 3.18 Mn |
| Sep 30, 2022 | 3.18 Mn |
| Jun 30, 2022 | 4.91 Mn |
| Jun 30, 2022 | 4.91 Mn |
| Mar 31, 2022 | 9.08 Mn |
| Mar 31, 2022 | 9.08 Mn |
| Dec 31, 2021 | 5.03 Mn |
| Dec 31, 2021 | 5.03 Mn |
| Sep 30, 2021 | 13.90 Mn |
| Sep 30, 2021 | 13.90 Mn |
| Jun 30, 2021 | 1.50 Mn |
| Jun 30, 2021 | 1.50 Mn |
| Mar 31, 2021 | -1.83 Mn |
| Mar 31, 2021 | -1.83 Mn |
| Dec 31, 2020 | -19.81 Mn |
| Dec 31, 2020 | -19.81 Mn |
| Sep 30, 2020 | 5.10 Mn |
| Sep 30, 2020 | 5.10 Mn |
| Jun 30, 2020 | 4.29 Mn |
| Jun 30, 2020 | 4.29 Mn |
| Mar 31, 2020 | -1.90 Mn |
| Mar 31, 2020 | -1.90 Mn |
| Dec 31, 2019 | -5.16 Mn |
| Dec 31, 2019 | -5.16 Mn |
| Sep 30, 2019 | -702,000.00 |
| Sep 30, 2019 | -702,000.00 |
| Jun 30, 2019 | 3.35 Mn |
| Jun 30, 2019 | 3.35 Mn |
| Mar 31, 2019 | -62,000.00 |
| Mar 31, 2019 | -62,000.00 |
| Dec 31, 2018 | -23.09 Mn |
| Dec 31, 2018 | -23.09 Mn |
| Sep 30, 2018 | 16.60 Mn |
| Sep 30, 2018 | 16.60 Mn |
| Jun 30, 2018 | 2.16 Mn |
| Jun 30, 2018 | 2.16 Mn |
| Mar 31, 2018 | 10.00 Mn |
| Mar 31, 2018 | 10.00 Mn |
| Dec 31, 2017 | -5.54 Mn |
| Dec 31, 2017 | -5.54 Mn |
| Sep 30, 2017 | 4.40 Mn |
| Sep 30, 2017 | 4.40 Mn |
| Jun 30, 2017 | 3.28 Mn |
| Jun 30, 2017 | 3.28 Mn |
| Mar 31, 2017 | -1.30 Mn |
| Mar 31, 2017 | -1.30 Mn |
| Dec 31, 2016 | -13.04 Mn |
| Dec 31, 2016 | -13.04 Mn |
| Sep 30, 2016 | 16.02 Mn |
| Sep 30, 2016 | 16.02 Mn |
| Jun 30, 2016 | 2.79 Mn |
| Jun 30, 2016 | 2.79 Mn |
| Mar 31, 2016 | 2.70 Mn |
| Mar 31, 2016 | 2.70 Mn |
| Dec 31, 2015 | 26.28 Mn |
| Dec 31, 2015 | 26.28 Mn |
| Sep 30, 2015 | -29.99 Mn |
| Sep 30, 2015 | -29.99 Mn |
| Jun 30, 2015 | 29.42 Mn |
| Jun 30, 2015 | 29.42 Mn |
| Dec 31, 2014 | -544,000.00 |
| Dec 31, 2014 | -544,000.00 |
| Jun 30, 2014 | -32.98 Mn |
| Jun 30, 2014 | -32.98 Mn |
| Mar 31, 2014 | 4,664.00 |
| Mar 31, 2014 | 4,664.00 |
| Dec 31, 2013 | 59,737.00 |
| Dec 31, 2013 | 59,737.00 |
| Sep 30, 2013 | 5.80 Mn |
| Sep 30, 2013 | 5.80 Mn |